FDA Regulations Li-Anne Rowswell Mufson FDA Regulations Li-Anne Rowswell Mufson

Continuous Manufacturing and ICH Q13: Regulatory Readiness at Scale

Guided by the landmark ICH Q13 guidelines,  the global pharmaceutical industry is undergoing a revolutionary shift from traditional batch manufacturing to agile, continuous production systems. Read this Week's Guard Rail to explore the revolutionary shift from traditional batch manufacturing to agile, continuous production systems. 

Read More